Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

NETSPOT

GALLIUM DOTATATE GA-68

Standard Dose
2.1-5.5mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NETSPOT is listed in Drugs@FDA under application 208547 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GALLIUM DOTATATE GA-68 Form and strength POWDER;INTRAVENOUS - 2.1-5.5mCi/ML Sponsor AAA USA INC Submission history Latest submission status date: 2023-10-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview NETSPOT is listed in Drugs@FDA under application 208547 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GALLIUM DOTATATE GA-68 Form and strength POWDER;INTRAVENOUS - 2.1-5.5mCi/ML Sponsor AAA USA INC Submission history Latest submission status date: 2023-10-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.